Home
About
Overview
Sharing Data
ORCID
Help
History (2)
CR2-mediated targeting of complement inhibitors: bench-to-bedside using a novel strategy for site-specific complement modulation.
Financial burden experienced by patients undergoing treatment for malignant gliomas.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Financial burden experienced by patients undergoing treatment for malignant gliomas.
Financial burden experienced by patients undergoing treatment for malignant gliomas. Neurooncol Pract. 2014 Jun; 1(2):71-76.
View in:
PubMed
authors with profiles
Charles Lee Bennett